Clinical Trial Update: Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti- PD-1 [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating fecal microbiota transplant capsules to boost the efficacy of anti-PD-1 therapy in gastrointestinal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Cancer

Drugs mentioned

• Anti-PD-1 therapy
• Fecal Microbiota Transplant Capsule (fecal microbiota transplant capsule)

Snippet

Sponsor: Peking University | Conditions: Gastrointestinal System Cancer | Phase 1 | Status: COMPLETED